The National and Kapodistrian University of Athens, usually referred to simply as the University of Athens, is a public university in Athens, Greece.

During the past decade, University of Athens conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 4 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 3 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Athens" #1 sponsor was "National and Kapodistrian University of Athens" with 7 trials, followed by "Harokopio University" with 5 trials sponsored, "Celgene" with 2 trials sponsored, "University of Athens" with 2 trials sponsored and "Aristotle University Of Thessaloniki" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Athens" #1 collaborator was "National and Kapodistrian University of Athens" with 6 trials as a collaborator, "European University Cyprus" with 2 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator, "Bar-Ilan University, Israel" with 1 trials as a collaborator and "Beder College University. Albania" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "University of Athens" are "Multiple Myeloma" (3 trials), "Appetite" (2 trials), "Quality of Life" (2 trials), "AV Fistula" (1 trials) and "Acceptance Process" (1 trials). Many other conditions were trialed in "University of Athens" in a lesser frequency.

Most popular intervention types in "University of Athens" are "Drug" (13 trials), "Other" (9 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "0.8 protein" (1 trials), "1.5 protein" (1 trials), "5Fluorouracil" (1 trials) and "ACCEPTANCE-BASED INTERVENTION" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Athens" are 27 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Athens". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in University of Athens, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Athens, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".